Aine Miller - Feb 6, 2024 Form 3 Insider Report for Theravance Biopharma, Inc. (TBPH)

Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Stock symbol
TBPH
Transactions as of
Feb 6, 2024
Transactions value $
$0
Form type
3
Date filed
2/16/2024, 08:12 PM
Next filing
Feb 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TBPH Ordinary Shares 145K Feb 6, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TBPH Share Option (Right to Buy) Feb 6, 2024 Ordinary Shares 37.5K $25.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to option vesting and became exercisable on March 2, 2021, then 1/48th of the shares subject to the option vest and became exercisable each month thereafter. The Option shall be fully vested and exercisable on March 2, 2024 provided optionee has remained in continuous service through such date.